UPDATE 1-Ebola vaccine trial halted temporarily for checks after joint pains - Geneva hospital

GENEVA, Dec 11 (Reuters) - A clinical trial of an Ebola vaccine developed by Merck and NewLink has been halted temporarily as a precautionary measure after four patients complained of joint pains, the University of Geneva Hospital said on Thursday.